-

Trinity Life Sciences Announces the Appointment of Paul R. Lucchese as General Counsel

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity Life Sciences, a global leader in life sciences solutions, today announced the appointment of Paul R. Lucchese as General Counsel and a member of the executive operating committee, reporting directly to Rebecca McNamara, Trinity’s Chief Financial Officer and Head of Corporate Operations. He will be responsible for leading Trinity’s legal operations and global compliance activities.

Mr. Lucchese has extensive experience as a General Counsel in high-growth technology-forward organizations including Aspect Software, Candela Corporation, Aternity, Inc. and EnterpriseDB. He also was the President of Outsourced General Counsel, a firm that provided cost-effective legal services to technology companies.

“I’m pleased to have Paul join Trinity’s executive team,” said Rebecca McNamara, CFO and Head of Corporate Operations at Trinity. “Paul’s broad business knowledge and legal background make him a perfect advisor for our senior team during this high growth phase.”

“I’m most excited about the ongoing organic and acquisitive growth of Trinity and the opportunity to create additional technology solutions for our clients,” said Paul R. Lucchese, General Counsel, Trinity Life Sciences. “The potential to offer additional value to our life sciences clients through technology solutions that will allow them to bring life-changing products to market in a more efficient and effective way is a motivation for me.”

Mr. Lucchese holds an MBA from Suffolk University, a JD from the University of Dayton School of Law and a BA from Providence College.

“The Trinity team is a collection of highly intelligent people who are acutely aware of the opportunities in front of them,” continued Mr. Lucchese. “I am already thriving on this energy.”

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic commercialization partner, providing evidence-based solutions for the life sciences. With 25 years of experience, Trinity is committed to revolutionizing the commercial model by providing exceptional levels of service, powerful tools and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Trinity Life Sciences


Release Versions

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Social Media Profiles
More News From Trinity Life Sciences

Trinity Sponsors Prix Galien UK Award for Innovation in Health Equity

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, is sponsoring the Best Health Equity Innovation category at the 2026 Prix Galien UK Awards, one of the most prestigious global honors recognizing excellence in biopharmaceutical research and innovation. The awards ceremony will take place June 11, 2026, at the Natural History Museum in London, bringing together leading scientists, healthcare innovators, pol...

Trinity Ranked Top Health Sciences Consulting Firm in 2026 Vault Consulting Rankings

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, has been named one of the world’s top health sciences consulting firms in the 2026 Vault Consulting Rankings. Vault Consulting’s 2026 report ranked Trinity in two categories: Health Sciences Consulting: Ranked #7 Most Prestigious Consulting Firms: Ranked #48 “We’re honored to be recognized among the top health sciences consulting firms by Vault. This achiev...

Trinity Appoints Scott Evangelista as CEO to Lead Next Chapter

WALTHAM, Mass.--(BUSINESS WIRE)--Trinity, a global leader in technology-enabled commercialization solutions for the life sciences industry, today announced Scott Evangelista has been appointed Chief Executive Officer, succeeding Leslie Orne who is stepping down after three years as CEO and over 24 years with the company. Ms. Orne will transition to the role of Senior Advisor and serve as a member of Trinity’s Board of Directors. Over her distinguished tenure, Ms. Orne helped guide Trinity’s evo...
Back to Newsroom